HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CON

Concentra Group Holdings Parent, Inc. (NYSE)

Healthcare — Medical Care Facilities

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

Strong Buy 1.3 / 5 8 analysts
$30.77
+$1.02 (+3.43%)
Target: $31.50 (2.4%)
Sign in to add CON to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$3.94B
P/E Ratio (TTM)22.14
Forward P/E18.20
EPS (TTM)$1.39
Dividend Yield0.81%
Profit Margin7.97%
Revenue Growth13.70%
ROE47.00%
Debt/Equity467.74
Recommendation Strong Buy 1.3
Analyst Target$31.50
Analysts8
Indexes NYSE

Technical Indicators

RSI (14)89.1
Beta-
SMA 20-
SMA 40-
52-Week High$30.90
52-Week Low$18.55
50-Day Avg$25.72
200-Day Avg$22.30
Avg Volume877.5K
Volume$1.93M

Performance Analysis

NEUTRAL

CON presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($30.90), which may indicate limited upside.
- RSI at 89.1 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 13.7% year-over-year.
+ Wall Street consensus is "Strong Buy" from 8 analysts.
+ Average analyst target of $31.50 implies 2.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:04 UTC

Back to Screener Export Report